These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16353971)

  • 1. Feasibility of transdermal delivery of fluoxetine.
    Parikh DK; Ghosh TK
    AAPS PharmSciTech; 2005 Sep; 6(2):E144-9. PubMed ID: 16353971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of permeation enhancers on transdermal delivery of fluoxetine: in vitro and in vivo evaluation.
    Jung E; Kang YP; Yoon IS; Kim JS; Kwon SW; Chung SJ; Shim CK; Kim DD
    Int J Pharm; 2013 Nov; 456(2):362-9. PubMed ID: 24012861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
    Aboofazeli R; Zia H; Needham TE
    Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal delivery of zalcitabine: in vitro skin permeation study.
    Kim DD; Chien YW
    AIDS; 1995 Dec; 9(12):1331-6. PubMed ID: 8605052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal delivery of zidovudine (AZT): the effects of vehicles, enhancers, and polymer membranes on permeation across cadaver pig skin.
    Suwanpidokkul N; Thongnopnua P; Umprayn K
    AAPS PharmSciTech; 2004 Aug; 5(3):e48. PubMed ID: 15760081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of fatty acids on the transdermal delivery of donepezil: in vitro and in vivo evaluation.
    Choi J; Choi MK; Chong S; Chung SJ; Shim CK; Kim DD
    Int J Pharm; 2012 Jan; 422(1-2):83-90. PubMed ID: 22037444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of drug-in-adhesive patch formulations for transdermal delivery of fluoxetine: In vitro and in vivo evaluations.
    Jung E; Lee EY; Choi HK; Ban SJ; Choi SH; Kim JS; Yoon IS; Kim DD
    Int J Pharm; 2015 Jun; 487(1-2):49-55. PubMed ID: 25863117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems.
    Babu RJ; Pandit JK
    Int J Pharm; 2005 Jan; 288(2):325-34. PubMed ID: 15620873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of the structure and the composition of water/AOT-Tween 85/IPM microemulsion system on transdermal delivery of 5-fluorouracil.
    Yanyu X; Fang L; Qineng P; Hao C
    Drug Dev Ind Pharm; 2012 Dec; 38(12):1521-9. PubMed ID: 22324326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of permeation enhancers on the release of ketoprofen through transdermal drug delivery systems.
    Singh SK; Durrani MJ; Reddy IK; Khan MA
    Pharmazie; 1996 Oct; 51(10):741-4. PubMed ID: 8941942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Microemulsion-based gel of fluorouracil for transdermal delivery].
    Xiao YY; Liu F; Chen ZP; Ping QN
    Yao Xue Xue Bao; 2010 Nov; 45(11):1440-6. PubMed ID: 21361046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(5):48-55. PubMed ID: 10171148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(6):28-33. PubMed ID: 10171149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a transdermal patch of methadone: in vitro evaluation across hairless mouse and human cadaver skin.
    Ghosh TK; Bagherian A
    Pharm Dev Technol; 1996 Oct; 1(3):285-91. PubMed ID: 9552311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microemulsion-based patch for transdermal delivery of huperzine A and ligustrazine phosphate in treatment of Alzheimer's disease.
    Shi J; Cong W; Wang Y; Liu Q; Luo G
    Drug Dev Ind Pharm; 2012 Jun; 38(6):752-61. PubMed ID: 22014311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of chemical enhancers on percutaneous absorption of daphnetin in isopropyl myristate vehicle across rat skin in vitro.
    Wen Z; Fang L; He Z
    Drug Deliv; 2009 May; 16(4):214-23. PubMed ID: 19280376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combination of nonionic surfactants and iontophoresis to enhance the transdermal drug delivery of ondansetron HCl and diltiazem HCl.
    Silva SM; Hu L; Sousa JJ; Pais AA; Michniak-Kohn BB
    Eur J Pharm Biopharm; 2012 Apr; 80(3):663-73. PubMed ID: 22137964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vehicle systems, pH and enhancers on the permeation of highly lipophilic aripiprazole from Carbopol 971P gel systems across human cadaver skin.
    Hossain MA; Ahmed SU; Plakogiannis FM
    Drug Dev Ind Pharm; 2012 Mar; 38(3):323-30. PubMed ID: 22067044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of solvents and penetration enhancers on transdermal delivery of thymoquinone: permeability and skin deposition study.
    Haq A; Michniak-Kohn B
    Drug Deliv; 2018 Nov; 25(1):1943-1949. PubMed ID: 30463442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modelling of pecutaneous drug permeation and investigation of penetration enhancer effect].
    Csizmazia E; Berkó S; Maroda M; Szabóné RP; Csányi E
    Acta Pharm Hung; 2012; 82(1):15-22. PubMed ID: 22570983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.